GESTATIONAL TROPHOBLASTIC DISEASES: FOURTEEN YEAR EXPERIENCE OF OUR CLINIC

被引:4
|
作者
Kurdoglu, Mertihan [1 ]
Kurdoglu, Zehra [1 ]
Kucukaydin, Zehra [1 ]
Sahin, Hanim Guler [1 ]
Kamaci, Mansur [1 ]
机构
[1] Yuzuncu Yil Univ, Fac Med, Dept Gynecol & Obstet, Van, Turkey
关键词
gestational trophoblastic disease; hydatidiform mole; incidence;
D O I
10.5505/tjod.2011.98470
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the patients followed and treated with a diagnosis of gestational trophoblastic disease in our clinic retrospectively. Design: The files of the patients followed and treated in our clinic between 1996 and 2010 with a diagnosis of gestational trophoblastic disease were examined. Setting: Yuzuncu YIl University, Faculty of Medicine, Department of Obstetrics and Gynecology, Van. Patients: The 147 patients with satisfactory information in their files within 173 patients treated and followed in our clinic between 1996 and 2010 with a diagnosis of gestational trophoblastic disease. Interventions: No intervention to the patients. Main outcome measures: Demographic and obstetric parameters, blood group, obstetric history in the previous pregnancy, contraceptive method, gestational week and complaints on admission, hystological type, stage, treatment and complications of gestational trophoblastic disease and presence of associated clinical problems. Results: In our clinic, 18.324 deliveries occured and 173 cases had a diagnosis of gestational trophoblastic disease between 1996 and 2010. Out of 147 patients, 72 (49%), 61 (41.5%), 3 (2%), 7 (4.8%) and 1 (0.7%) had diagnoses of complete mole, partial mole, invasive mole, choriocarcinoma and placental site trophoblastic tumor, respectively. In 3 patients ( 2%), subtype could not be determined. Mean age was 31.45 +/- 10.29 years and the most common complaint was vaginal bleeding (77.6%). As the primary therapy, suction curettage with oxytocin infusion or hysterectomy was appplied to 140 and 7 patients, respectively. A single agent chemotherapy was performed to 26 patients while a multiagent chemotherapy was given to 6 patients. All patients were followed up by serial serum beta-hCG measurements. Conclusions: The incidence of gestational trophoblastic disease in our clinic was calculated as 8.1 per 1000 deliveries and socio-economic and educational status of majority of the patients were low. Lowering the high birth rate in our region may contribute to decrease of disease incidence.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 50 条
  • [41] Expression of epidermal growth factor and its receptor in gestational trophoblastic diseases
    李宁
    袁育康
    刘惠喜
    Journal of Medical Colleges of PLA, 2005, (01) : 62 - 64
  • [42] Proportion Hyperglycosylated hCG A New Test for Discriminating Gestational Trophoblastic Diseases
    Cole, Laurence A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1709 - 1714
  • [43] Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta
    Singh, Margit
    Kindelberger, David
    Nagymanyoki, Zoltan
    Ng, Shu-Wing
    Quick, Charles M.
    Elias, Kevin M.
    Yamamoto, Hidemi
    Fichorova, Raina
    Fulop, Vilmos
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2011, 122 (01) : 178 - 182
  • [44] Vaginal metastasis in gestational trophoblastic neoplasia: Experience from Sheffield trophoblastic disease Centre and recommendations for management
    Parker, V. L.
    Hodson, E. M. D.
    Singh, K.
    Winter, M. C.
    Palmer, J. E.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2025, 305 : 23 - 30
  • [45] Gestational trophoblastic disease in a fifty-one year old woman
    Cantuaria, GHC
    Angioli, R
    Messore, M
    Estape, R
    Penalver, M
    ONCOLOGY REPORTS, 1997, 4 (01) : 149 - 151
  • [46] A Histopathological Profile of Gestational Trophoblastic Disease in the Madinah Region of Saudi Arabia: A Single Institute Experience
    Almohammadi, N. H.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2022, 25 (08) : 1256 - 1261
  • [47] The importance of AgNOR method in the prognosis and comparison with some clinic parameters in gestational trophoblastic disease
    Oltulu, Pembe
    Gezginc, Kazim
    Yilmaz, Osman
    Celik, Cetin
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 3 (03) : 195 - 201
  • [48] Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience
    H. Al-Husaini
    H. Soudy
    A. Darwish
    M. Ahmed
    A. Eltigani
    W. Edesa
    T. Elhassan
    A. Omar
    W. Elghamry
    H. Al-Hashem
    S. Al-Hayli
    I. Madkhali
    S. Ahmad
    I. A. Al-Badawi
    Clinical and Translational Oncology, 2015, 17 : 409 - 415
  • [49] Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience
    Al-Husaini, H.
    Soudy, H.
    Darwish, A.
    Ahmed, M.
    Eltigani, A.
    Edesa, W.
    Elhassan, T.
    Omar, A.
    Elghamry, W.
    Al-Hashem, H.
    Al-Hayli, S.
    Madkhali, I.
    Ahmad, S.
    Al-Badawi, I. A.
    Clinical & Translational Oncology, 2015, 17 (05) : 409 - 415
  • [50] Gestational trophoblastic diseases - Recent advances in histopothologic diagnosis and related genetic aspects
    Hui, P
    Martel, M
    Parkash, V
    ADVANCES IN ANATOMIC PATHOLOGY, 2005, 12 (03) : 116 - 125